Gene expression profiling in breast cancer: a clinical perspective.
about
Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic MedicineThe impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysisSignatures of breast cancer metastasis at a glanceTranslating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast CancerAnalytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimensImpact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer.Quantitative risk stratification of oral leukoplakia with exfoliative cytologyGenomic classification of the RAS network identifies a personalized treatment strategy for lung cancerComparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group StudyThe value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidencePersonalized medicine and the clinical laboratory.Triple Negative Breast Cancer: Nanosolutions for a Big Challenge.High-grade poorly differentiated neuroendocrine carcinoma of the breast with low oncotype Dx recurrence score: A case report.Quantitative prediction of oral cancer risk in patients with oral leukoplakia.A new ten-gene risk fraction model serving as prognostic indicator for clinical outcome of multiple myeloma.Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure.Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myeloma.Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.Adjuvant therapeutic decisions in elderly breast cancer patients: the role of chemotherapy in a retrospective analysis.The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patients.Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab.Genomic profile of breast cancer: cost-effectiveness analysis from the Spanish National Healthcare System perspective.Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis.Epigenetics and Precision Oncology.Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?Performance characteristics of the MammaPrint®breast cancer diagnostic gene signature
P2860
Q26740365-CE43ED67-B1C1-4253-A099-F9F60FA7A689Q26861418-5722C403-4A74-44D4-84BB-BA7BAD9A0738Q28071451-6E9D4EC7-7C0A-4B1D-9A62-357E0AA17C49Q31015478-8AD35670-E802-4C98-9AF6-9C2F5784486AQ33559365-6AFD1712-E1CF-4DBA-BCCC-B1352B31385BQ34141851-1E04141D-6C87-4D20-8E47-E1F6594E52B1Q35610734-E8F94786-AF23-4C31-BDC4-ECE3687B2429Q35670290-D5298CA2-6C8A-4FCD-A06E-EAD99DCEC522Q36151341-6628ACA6-03EE-46AB-A98F-62C64588DAD8Q36462893-20DB7357-DB27-47EA-8B0C-6D1C6416B697Q36916966-F23410E1-4EB0-47F8-A06B-B038BDB9B92CQ37422972-84CF1237-47E6-4197-8A79-2647DB849B15Q38706578-E9D8AE18-B637-4308-B497-F758781B9F7BQ38763495-00D4A15D-45A0-4811-938A-AC4417ACD79EQ39317632-BF7C3337-6DF1-4C3B-9A28-4EBB581B5ACCQ40143160-B066F0F2-D455-4197-9117-C1C46E06F364Q40257510-0B10DEAA-F8C5-4700-A3AB-2010A09C3CECQ40629175-A7C5FDDC-A84A-40BB-9C65-093AAC003EF9Q40984871-2936E95D-F0AD-449E-8800-50F1CD9BB2DEQ45771015-A7C68584-34B9-4611-A7A2-5048041633FAQ47563512-6409BBC7-50B4-467E-AAFA-DE8CAA3877D6Q48065668-F9598554-F39B-4895-A659-E8DB77725C51Q49948404-C6EA67A9-BB57-4B53-B8BA-D4E4BDCF6F7DQ50020927-4215CA13-AE74-431C-B050-A805371FAFF8Q53838654-3B6EF1D4-0B6F-47A8-91D8-F4AB4E1D6959Q57541319-2393E29A-59F2-415E-87E2-9AB3025F204D
P2860
Gene expression profiling in breast cancer: a clinical perspective.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Gene expression profiling in breast cancer: a clinical perspective.
@en
type
label
Gene expression profiling in breast cancer: a clinical perspective.
@en
prefLabel
Gene expression profiling in breast cancer: a clinical perspective.
@en
P2093
P50
P1433
P1476
Gene expression profiling in breast cancer: a clinical perspective
@en
P2093
Alberto Bottini
Alfredo Berruti
Andrea Antonelli
Antonio Frassoldati
Daniele Generali
Giorgio Mustacchi
Grazia Arpino
Luigi Dogliotti
Marina Cazzaniga
Mario Martinotti
P304
P356
10.1016/J.BREAST.2013.01.016
P50
P577
2013-02-23T00:00:00Z